MedPath

THE TEMSTEM TRIAL: Reducing distress and dysfunction caused by auditory verbal hallucinations via a smartphone application.

Completed
Conditions
hallucinations
voice hearing
10039628
Registration Number
NL-OMON45092
Lead Sponsor
Vrije Universiteit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

* Presence of AVHs (with distress) for longer than a month
* Presence of AVHs during a minimum of four days a week, in at least three of the last four weeks

Exclusion Criteria

* Changes in medication regiment in the last month
* Estimated IQ under 70; the researchers will examine the schoolcareer of the patient. If problems during the primaryschool period are found, the short version of the WAIS-IV will be conducted to determine intelligence.
* Insufficient competence in the Dutch language
* Previous use of temstem
* Not willing or able to learn to use a smartphone
* Currently undergoing cognitive behavioural therapy for AVHs
* Current involuntary admission in a closed ward

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcomes are changes in distress, disturbance to life and social<br /><br>dysfunction caused by AVHs. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Changes in frequency and severity of AVHs; control and power over AVHs; ability<br /><br>to cope with AVHs; self-esteem; depression; quality of life; paranoid<br /><br>ideations.</p><br>
© Copyright 2025. All Rights Reserved by MedPath